Cargando…
HER2基因状态与晚期肺腺癌患者一线培美曲塞联合铂类化疗疗效的关系
BACKGROUND AND OBJECTIVE: Human epidermal growth factor receptor 2 (HER2) is one of the driver genes of non-small cell lung cancer (NSCLC). Several studies have shown that the efficacy of pemetrexed in HER2-mutant NSCLC is controversial. The aim of this study is to investigate the efficacy of pemetr...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441116/ https://www.ncbi.nlm.nih.gov/pubmed/30909992 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.03.03 |